Eyevensys Recaps Highlights from Investigator Meeting and Presentations at the ARVO 2022 Annual Conference
Eyevensys Recaps Highlights from Investigator Meeting and Presentations at the ARVO 2022 Annual Conference https://eyevensys.com/wp-content/uploads/2020/02/christian-wiediger-PSmDDeXaEWE-unsplash-1.jpg 1667 2500 Eyevensys https://eyevensys.com/wp-content/uploads/2020/02/christian-wiediger-PSmDDeXaEWE-unsplash-1.jpgParis, France, and Cambridge, Mass., United States, May 11, 2022 — Eyevensys, a privately held, clinical-stage biotechnology company developing non-viral gene therapies for ophthalmic diseases, today provided highlights from the…